These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 33815279

  • 1. Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease.
    Akirov A, Larouche V, Shimon I, Asa SL, Mete O, Sawka AM, Gentili F, Ezzat S.
    Front Endocrinol (Lausanne); 2021; 12():620005. PubMed ID: 33815279
    [Abstract] [Full Text] [Related]

  • 2. The role of Crooke's changes in recurrence and remission after gamma knife radiosurgery.
    Cordeiro D, Xu Z, Nasser M, Lopes B, Vance ML, Sheehan J.
    J Neurooncol; 2019 Mar; 142(1):171-181. PubMed ID: 30607704
    [Abstract] [Full Text] [Related]

  • 3. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
    Oldfield EH, Vance ML, Louis RG, Pledger CL, Jane JA, Lopes MB.
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
    [Abstract] [Full Text] [Related]

  • 4. Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs.
    Eschbacher JM, Coons SW.
    Endocr Pathol; 2006 Aug; 17(4):365-76. PubMed ID: 17525485
    [Abstract] [Full Text] [Related]

  • 5. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
    Roncaroli F, Faustini-Fustini M, Mauri F, Asioli S, Frank G.
    Endocr Pathol; 2002 Aug; 13(3):245-9. PubMed ID: 12446925
    [Abstract] [Full Text] [Related]

  • 6. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B, Maksymowicz M, Pękul M, Zieliński G.
    Front Endocrinol (Lausanne); 2021 Aug; 12():672178. PubMed ID: 34135861
    [Abstract] [Full Text] [Related]

  • 7. The pathology of Cushing's disease.
    Kovacs K.
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):179-82. PubMed ID: 8481343
    [Abstract] [Full Text] [Related]

  • 8. Ubiquitin immunoreactivity in corticotrophs following glucocorticoid treatment and in pituitary adenomas.
    Marin F, Cheng Z, Kovacs K.
    Arch Pathol Lab Med; 1993 Mar; 117(3):254-8. PubMed ID: 8382913
    [Abstract] [Full Text] [Related]

  • 9. Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease.
    Hague K, Post KD, Morgello S.
    Surg Neurol; 2000 Jan; 53(1):77-81. PubMed ID: 10697237
    [Abstract] [Full Text] [Related]

  • 10. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
    George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF, Lloyd RV, Meyer FB.
    Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
    [Abstract] [Full Text] [Related]

  • 11. Pituitary corticotroph adenoma with crooke's hyalinization.
    Franscella S, Favrod-Coune CA, Pizzolato G, Asa SL, Gaillard R, Berney J, Philippe J.
    Endocr Pathol; 1991 Jun; 2(2):111-116. PubMed ID: 32357610
    [Abstract] [Full Text] [Related]

  • 12. Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors.
    Pękul M, Szczepaniak M, Kober P, Rusetska N, Mossakowska BJ, Baluszek S, Kowalik A, Maksymowicz M, Zieliński G, Kunicki J, Witek P, Bujko M.
    Front Endocrinol (Lausanne); 2024 Jun; 15():1302667. PubMed ID: 38487343
    [Abstract] [Full Text] [Related]

  • 13. Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary.
    Vrontakis ME, Sano T, Kovacs K, Friesen HG.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):747-51. PubMed ID: 1689739
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM, Perry A, McClaskey J, Inzucchi SE, James WS, Eid T, Bronen RA, Mahajan A, Huttner A, Santos F, Spencer D.
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [Abstract] [Full Text] [Related]

  • 15. Identification of corticotrophs in the human pituitary with mAB lu-5, a novel immunocytochemical marker.
    Kovacs K, Ryan N, Stefaneanu L.
    Pathol Res Pract; 1987 Dec; 182(6):775-9. PubMed ID: 2449679
    [Abstract] [Full Text] [Related]

  • 16. Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.
    Hinojosa-Amaya JM, Lam-Chung CE, Cuevas-Ramos D.
    Front Endocrinol (Lausanne); 2021 Dec; 12():657382. PubMed ID: 33986726
    [Abstract] [Full Text] [Related]

  • 17. Corticotroph hyperplasia and Cushing disease: diagnostic features and surgical management.
    Catalino MP, Meredith DM, De Girolami U, Tavakol S, Min L, Laws ER.
    J Neurosurg; 2021 Jul 01; 135(1):152-163. PubMed ID: 32886921
    [Abstract] [Full Text] [Related]

  • 18. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
    Tanaka S, Yamamoto M, Morita M, Takeno A, Kanazawa I, Yamaguchi T, Yamada S, Inoshita N, Oki Y, Kurosaki M, Sugimoto T.
    Endocr J; 2019 Aug 29; 66(8):701-708. PubMed ID: 31130573
    [Abstract] [Full Text] [Related]

  • 19. Distribution of Crooke's cells and ACTH cells in the human pituitary glands.
    Takahashi K, Andoh N, Mouri T, Sasano N.
    Tohoku J Exp Med; 1988 Aug 29; 155(4):379-83. PubMed ID: 2852858
    [Abstract] [Full Text] [Related]

  • 20. Fine structure of Crooke's hyaline change in the human pituitary gland.
    DeCicco FA, Dekker A, Yunis EJ.
    Arch Pathol; 1972 Jul 29; 94(1):65-70. PubMed ID: 4113498
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.